Great Debates: ctDNA: Is It Ready for Prime Time? (2023 AMW)
2023 AAO-HNSF Annual Meeting & OTO Experience
In this great debate hear experts debate the pros and cons of Circulating Tumor DNA (ctDNA) in the treatment of head and neck cancer, review current research outside of head and neck cancer in how ctDNA has treated colon cancer and urothelial carcinoma, and Discuss reasons why it's ready for prime time and could be implemented into your practice.
Credits
CME:1.0, MOC:1.0